High-dose cytarabine salvage therapy for recurrent primary CNS lymphoma
Crossref DOI link: https://doi.org/10.1007/s11060-015-1994-8
Published Online: 2015-11-13
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chamberlain, Marc C.
Text and Data Mining valid from 2015-11-13